Wi-Fi, Smartphones, and Surveillance: The New Face of Schizophrenia Delusions
December 18, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
N/A
Synonyms :
ficonalkibum, CT-3505, SY-3505, Ficonalkib
Class :
Antineoplastic agent
Brand Name :
N/A
Synonyms :
ficonalkibum, CT-3505, SY-3505, Ficonalkib
Class :
Antineoplastic agent
Dosage Forms & Strengths
Respiratory disease
This drug is indicated in treating neoplasms and other diseases that are ALK-mediated.
It has completed Phase- 2 of clinical trials and entered Phase 3
This drug is indicated in treating neoplasms and other diseases that are ALK-mediated.
It has completed Phase- 2 of clinical trials and entered Phase 3
Dosage Forms & Strengths
Data not available
Refer to adult dosing
Actions and Spectrum
It acts by inhibiting the ALK-anaplastic lymphoma kinase which is a tyrosine kinase inhibitor.
Frequency not defined
Information on adverse events is not available
Black Box Warning
No specific black box warnings are available for this drug
Contraindication/Caution:
Contraindication:
No contraindications are available for this drug, as it is in phase-3 clinical trials
Pregnancy consideration:
Safety and efficacy study is not established in pregnant women
Lactation:
Safety and efficacy study is not established in lactating mothers
Pregnancy category:
Category A: Studies that were well-controlled and met expectations revealed no risk to the fetus in either the first or second trimester.
<b>Category B: There was a lack of studies on pregnant women and no evidence of risk to the fetus in animal experiments.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence, these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology
The exact pharmacology is not known
Pharmacodynamics
It acts by inhibiting the tyrosine kinase inhibitor known as ALK-anaplastic lymphoma kinase
Pharmacokinetics
No data available on the ADME
Administration
Under clinical trials
Patient information leaflet
Generic Name: ficonalkib
Why do we use ficonalkib?
Ficonalkib is an anaplastic lymphoma kinase inhibitor undergoing phase 3 of clinical trials. This drug is being studied for its use in treating ALK-positive respiratory neoplasm.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
